Evidence map›Paper›PMID 40430491›Full record

ArticlePharmaceuticals (Basel, Switzerland)2025

Lanthanides-Based Nanoparticles Conjugated with Rose Bengal for FRET-Mediated X-Ray-Induced PDT.

Batoul Dhaini, Joël Daouk, Hervé Schohn, Philippe Arnoux, Valérie Jouan-Hureaux, Albert Moussaron, Agnès Hagege, Mathilde Achard, Samir Acherar, Tayssir Hamieh and 1 more

Abstract read
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Batoul DhainiUniversité de Lorraine, CNRS, LRGP, F-54000 Nancy, France.
Joël DaoukUniversité de Lorraine, CNRS, CRAN, F-54000 Nancy, France.ORCID 0000-0001-8042-1726
Hervé SchohnUniversité de Lorraine, CNRS, CRAN, F-54000 Nancy, France.ORCID 0000-0002-3651-2636
Philippe ArnouxUniversité de Lorraine, CNRS, LRGP, F-54000 Nancy, France.ORCID 0000-0002-6834-9597
Valérie Jouan-HureauxUniversité de Lorraine, CNRS, CRAN, F-54000 Nancy, France.ORCID 0000-0003-1127-7067
Albert MoussaronUniversité de Lorraine, CNRS, LRGP, F-54000 Nancy, France.ORCID 0000-0002-1817-9278
Agnès HagegeUniversité Claude Bernard Lyon 1, CNRS, ISA, UMR 5280, F-69100 Villeurbanne, France.ORCID 0000-0002-9246-929X
Mathilde AchardUniversité de Lorraine, CNRS, LCPM, F-54000 Nancy, France.
Samir AcherarUniversité de Lorraine, CNRS, LCPM, F-54000 Nancy, France.ORCID 0000-0002-8776-1632
Tayssir HamiehLaboratory of Materials, Catalysis, Environment and Analytical Methods (MCEMA), Faculty of Sciences I, Lebanese University, Beirut P.O. Box 6573/1, Lebanon.ORCID 0000-0003-2153-7408
Céline FrochotUniversité de Lorraine, CNRS, LRGP, F-54000 Nancy, France.ORCID 0000-0002-7659-3864

Funding

We would like to thank Lebanese University for the funding of the PhD grant. Lebanese University
6 · The paper itself

Abstract

In order to find a good candidate for Förster Resonance Energy Transfer (FRET)-mediated X-ray-induced photodynamic therapy (X-PDT) for the treatment of cancer, lanthanide (Ln)-based AGuIX nanoparticles (NPs) conjugated with Rose Bengal (RB) as a photosensitizer (PS) were synthesized. X-PDT overcomes the problem of the poor penetration of visible light into tissues, which limits the efficacy of PDT in the treatment of deep-seated tumors. It is essential to optimize FRET efficiency by maximizing the overlap integral between donor emission and acceptor absorption and lengthening the duration of the donor emission. In this study, we optimized energy transfer between a scintillator (Sc) as a donor and a PS as an acceptor. Terbium (Tb) and Gadolinium (Gd) as Scs and Rose RB as a PS were chosen. The study of energy transfer between Tb, Gd and RB in solution and chelated on AGuIX NPs proved to be FRET-like. RB was conjugated directly onto AGuIX NPs (i.e., AGuIX Ln@RB), and the use of a spacer arm (i.e., AGuIX Ln@spacer arm-RB) increased FRET efficiency. Singlet oxygen production by these NPs was observed under UV-visible illumination and X-ray irradiation. The in vitro bioassay demonstrated 52% cell death of U-251MG derived from human malignant glioblastoma multiforme at a concentration of 1 μM RB after illumination and irradiation (2 Gy, 320 kV, 10 mA, 3 Gy/min at 47 cm). In addition, the RB-coupled NRP-1-targeting peptide (i.e., K(RB)DKPPR) was conjugated onto AGuIX NPs by a thiol-maleimide click chemistry reaction, and an affinity in the nM range was observed.

Indexed as

AGuIXfluorescence resonance energy transfer (FRET)gadoliniumglioblastomaNeuropilin 1 (NRP-1)peptidephotodynamic therapy induced by X ray (X-PDT)Rose Bengal (RB)terbium

Identifiers

PMID40430491
PMCPMC12114895

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.